Targeting HIV Entry: 3rd International Workshop

Conference Reports for NATAP


Targeting HIV Entry: 4th International Workshop Rio Grande, Puerto Rico December 8-9, 2008

	Enfuvirtide-Plus-Raltegravir Salvage Trial Cuts Off Recruitment Early - Written by Mark Mascolini - (12/10/08) HIV Becomes More Flexible in CCR5 and CXCR4 Use as Infection Progresses - Written by Mark Mascolini - (12/10/08) Low Enfuvirtide and Maraviroc Penetration of CSF--and CSF Resistance to Enfuvirtide - Written by Mark Mascolini - (12/10/08) Vicriviroc Phase 3 Trial and Naive Study May Afford New Angle on Role of CCR5 Blockers - Written by Mark Mascolini - (12/10/08) Almost 40% of Viruses in Treatment-Experienced German Group Use CXCR4 - Written by Mark Mascolini - (12/10/08)